Several studies have reported significantly increased RBP4 levels in patients with NAFLD [63–66], whereas other studies have shown no difference on RBP4 levels between control and NAFLD groups [67, 68]. The gene discussed is RBP4; the disease is metabolic dysfunction-associated steatotic liver disease.